INOpulse DS (inhaled nitric oxide)

nitric oxide · Bellerophon Pulse Technologies

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INOpulse DS (inhaled nitric oxide), covering 2023-02-27 to 2023-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) [Phase 2]